Economic Evaluetion of Fulvestrant 500 MG (F500) Versus Original Nonsteroidal Aromatase Inhibitors in Patient with Advanced Breast Canser in Russia (2 LINE THERAPY)

Value Health. 2014 Nov;17(7):A637. doi: 10.1016/j.jval.2014.08.2291. Epub 2014 Oct 26.
No abstract available